Sialoadenitis secondary to 131I therapy for well-differentiated thyroid cancer

Using Tc-99m Pertechnetate Scintigraphy to Predict the Outcome of Sialoendoscopy in Obstructive Submaxillaritis

(2010) Jie-Hua Xu et al.   CLINICAL NUCLEAR MEDICINE

Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer

(2010) Chao Ma et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment

(2010) M Blom et al.   ORAL DISEASES

Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation

(2009) R. K. Grewal et al.   JOURNAL OF NUCLEAR MEDICINE

Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis

(2009) Steven R. Bomeli et al.   LARYNGOSCOPE

Reducing the Incidence of 131I-Induced Sialadenitis: The Role of Pilocarpine

(2008) E. B. Silberstein   JOURNAL OF NUCLEAR MEDICINE

Limited Cytoprotective Effects of Amifostine in High-Dose Radioactive Iodine 131–Treated Well-Differentiated Thyroid Cancer Patients: Analysis of Quantitative Salivary Scan

(2008) Seong-Jang Kim et al.   THYROID